Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104177394B reveals a cost-effective Entecavir intermediate route with mild conditions, offering supply chain stability and high purity for antiviral drug production.
Patent CN100368388C details a novel Knoevenagel synthesis for cyano-substituted resveratrol analogues, offering enhanced antitumor activity and scalable production for pharmaceutical intermediates.
Patent CN102351849B reveals a novel one-pot synthesis for Olmesartan Medoxomil intermediates, offering high purity, reduced operational complexity, and scalable manufacturing solutions.
Patent CN111479800B reveals solid-phase synthesis for kappa opioid agonists. Offers high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN108299429B details a novel synthesis for octahydrobenzonaphthyridine compounds with enhanced antitumor activity and solubility, offering significant cost reduction in API manufacturing.
Patent CN105985990B details a green enzymatic route for phenylephrine intermediates using KRED and antioxidants, offering significant cost reduction in API manufacturing.
Novel process for pyrido-benzazepine intermediates via glutaraldehyde cyclization. Enhances purity and scalability for ACE inhibitor production.
Advanced synthesis of Chenodeoxycholic Acid via hypochlorite oxidation. High yield, low cost route for API manufacturing. Reliable pharmaceutical intermediates supplier.
Novel two-step process avoids acid chlorides. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN110317201B reveals a high-yield asymmetric route for Moxifloxacin intermediates. Discover cost-effective manufacturing and supply chain advantages.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Novel photocatalytic route for Piragliatin reduces steps and improves supply chain reliability for diabetes treatment intermediates globally.
Patent CN102010376A reveals a green aqueous synthesis for quinoxalines using biodegradable ionic liquids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN117865832A offers high purity synthesis for GLP-1 intermediates. Reduces impurities and simplifies scale-up for reliable pharmaceutical intermediate supply chains.
Patent CN1307142C reveals improved isoflurane purification reducing solvent loss and enhancing supply chain reliability for global pharmaceutical intermediates.
Novel succinic anhydride route for Canagliflozin intermediate. Reduces heavy metals, improves yield, ensures supply chain stability for pharmaceutical manufacturing.
Discover a cost-effective preparation method for Tedizolid phosphate intermediates using novel copper-catalyzed coupling, offering significant supply chain advantages.
Patent CN104151229B details a high-yield resolution process for Levamlodipine intermediates using DMSO-d6, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Patent CN102942542A details a cost-effective Ru-catalyzed route for 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid, offering significant supply chain advantages.